This rebound reflects not only a broader recovery in market sentiment but also a resurgence of investor interest in specific sectors like financial services and specialty chemicals—areas that struggled last year but are now showing encouraging signs of recovery and growth.
Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improve
Laurus Labs’ stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The company is investing